Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
Christina Pfab, Luisa Schnobrich, Samir Eldnasoury, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3193-3193
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug
Alice Njolke Mafe, Dietrich Büsselberg
Biomedicines (2025) Vol. 13, Iss. 2, pp. 422-422
Open Access | Times Cited: 3
Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
Divya Ajmeera, Rajanna Ajumeera
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 148-175
Open Access | Times Cited: 34
mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
Dariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access | Times Cited: 1
Repurposing antifungal drugs for cancer therapy
Ningna Weng, Zhe Zhang, Yunhan Tan, et al.
Journal of Advanced Research (2022) Vol. 48, pp. 259-273
Open Access | Times Cited: 29
Preparation and Characterization of Patch Loaded with Clarithromycin Nanovesicles for Transdermal Drug Delivery
Ahlam Zaid Alkilani, Batool Musleh, Rania Hamed, et al.
Journal of Functional Biomaterials (2023) Vol. 14, Iss. 2, pp. 57-57
Open Access | Times Cited: 21
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Yogita Dhas, Nupur Biswas, M R Divyalakshmi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 7
Efavirenz: History, Development and Future
Bárbara Costa, Nuno Vale
Biomolecules (2022) Vol. 13, Iss. 1, pp. 88-88
Open Access | Times Cited: 27
Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review
Shafina Siddiqui, Ankita Jaywant Deshmukh, Priyanka Mudaliar, et al.
Journal of the Egyptian National Cancer Institute (2022) Vol. 34, Iss. 1
Open Access | Times Cited: 22
The Interplay among Radiation Therapy, Antibiotics and the Microbiota: Impact on Cancer Treatment Outcomes
Kavery Nivana Theethira Poonacha, Tomás G. Villa, Vicente Notario
Antibiotics (2022) Vol. 11, Iss. 3, pp. 331-331
Open Access | Times Cited: 18
Microbes, macrophages, and melanin: a unifying theory of disease as exemplified by cancer
Stacie Z. Berg, Jonathan Berg
Frontiers in Immunology (2025) Vol. 15
Open Access
Repurposing antibiotics: A dual-action approach against bacteria-induced cancer
Aditya Upadhyay, Hem Chandra Jha, Dharm Pal, et al.
Cancer Pathogenesis and Therapy (2025)
Open Access
Hydrazone-bridged 5-nitrofuran and piperidine/piperazine derivatives: Synthesis, DFT studies, and evaluation of anticancer and antimicrobial activity
Turgut Şimşek, Esma Özcan, Yasin Çetinkaya, et al.
Journal of Molecular Structure (2025), pp. 141863-141863
Closed Access
Does anticancer therapy directly contribute to antimicrobial resistance?
Ishir Sharma, Richard Wilson, Nina Zhu, et al.
The Lancet Microbe (2025), pp. 101115-101115
Open Access
Therapeutic and Preventive Effects of Natural Compounds Derived from Microbes
Matthew Chidozie Ogwu, Odangowei Inetiminebi Ogidi, Sylvester Chibueze Izah, et al.
Springer eBooks (2025), pp. 1-34
Closed Access
Molecular Docking and Dynamics Simulation Revealed Ivermectin as Potential Drug against Schistosoma-Associated Bladder Cancer Targeting Protein Signaling: Computational Drug Repositioning Approach
Arif Jamal Siddiqui, Mohammad Faheem Khan, Walid Sabri Hamadou, et al.
Medicina (2021) Vol. 57, Iss. 10, pp. 1058-1058
Open Access | Times Cited: 23
Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction
Da Eun Lee, Hyeon Woong Kang, So Yi Kim, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 16
Mass Spectrometry-Based Chemical Proteomics for Drug Target Discoveries
Ivan I. Fedorov, Victoria I. Lineva, Irina A. Tarasova, et al.
Biochemistry (Moscow) (2022) Vol. 87, Iss. 9, pp. 983-994
Closed Access | Times Cited: 16
Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition
Sally A. Fahim, Yehia A. ElZohairy, Rehab I. Moustafa
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
GSH-Responsive and Folate Receptor-Targeted pyridine bisfolate-Encapsulated chitosan Nanoparticles for Enhanced Intracellular Drug Delivery in MCF−7 cells
Fawzya I. Elshami, Gehad Elrefaei, Mohamed M. Ibrahim, et al.
Carbohydrate Research (2024) Vol. 543, pp. 109207-109207
Closed Access | Times Cited: 3
Drug repurposing for cancer
Juni Banerjee, Anand Krishna Tiwari, Shuvomoy Banerjee
Progress in molecular biology and translational science (2024), pp. 123-150
Closed Access | Times Cited: 2
Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies
Keshav Raj Paudel, Manisha Singh, Gabriele De Rubis, et al.
Life Sciences (2024) Vol. 352, pp. 122859-122859
Open Access | Times Cited: 2
Drug repositioning identifies potential autophagy inhibitors for the LIR motif p62/SQSTM1 protein
Narjes Asghari, Ali Kian Saei, Marco Cordani, et al.
Computational Biology and Chemistry (2024) Vol. 113, pp. 108235-108235
Closed Access | Times Cited: 2
Investigations of nitazoxanide molecular targets and pathways for the treatment of hepatocellular carcinoma using network pharmacology and molecular docking
Shakeel Ahmad Khan, Terence K. Lee
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines
Eduarda Ribeiro, Diana Araújo, Mariana Pereira, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 799-799
Open Access | Times Cited: 6
The tale of antibiotics beyond antimicrobials: Expanding horizons
Shivani Yadav, Dhruvi Shah, Parmeswar Dalai, et al.
Cytokine (2023) Vol. 169, pp. 156285-156285
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top